You have all the information available to you, good and bad, and...

First 201 Last

Share
Profile

Follow
crossyaus

252 Posts.

03/08/17

17:50

Post #: 26274519
Share

Originally posted by RNClarke ↑

Management will actually be more than a year late from their original timeline.

The reason why is due to the scope of respiratory diseases being applied for simultaneously, number of hospitals included in the trial and volume of patients needed - but you wouldn't know this, as you haven't been following RAP from the early days.

ResApp have been valued comfortably at this 200M market cap level for the past year on zero revenue. The problem is the Motley Fools of the world just quite can't comprehend how this has been possible.

ResApp are just as much a business as they are a big data play, and there will be no alternative in the near future. A few contracts landed solely in the US with Telehealth providers and ResApp will be able to command a P/E of 30+ just like all other medical and biomed stocks which are unmatched in their field, you just have to look at the American markets to see how well they are priced. Except this time ResApp will also be trading cash flow positive.

Its amazing to see how many posters come out of the woodwork during these times, most remain quiet all year and provide little to no value in their posts. A lot of smoke blowing without understanding fundamentals, market size, let alone the Telehealth industry and the value proposition ResApp brings.

Next Wednesday we will see exceptional results, it only takes a few revisits to past presentations and announcements to see how bullish management are, and everyone will be jumping back in. The Motley Fools of the world will again have no idea why, and will write a few more negative pieces around $1, but the smart money by then will already holding RAP.

Expand

You have all the information available to you, good and bad, and you have made a choice to back the company. Definitive predictive statements about what you think will happen in the future don't make it any more likely to happen. Investing in this stock is not a risk free proposition, and all I can say to you is good luck.

RAP Price at posting: 31.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

LLL

Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng

RHI

Red Hill Minerals Signs $6.5 Million Agreement with Peel Mining to Explore Curnamona Project, NSW

ITM

Fast-track assaying yields 182 g/t gold for iTech at new NT play

STN

Saturn’s stars have aligned for the gold explorer’s Apollo Project

Climate change to drive market trends to the moon

The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

KGL

KGL sniffs 19% Cu from drilling at Rockface play in NT

TVN

Tivan and EARTH AI gear up to commence fresh drilling at Sandover lead-silver project, NT

Week 27 Wrap: "Election year" is here as UK Labour win contrasts France; Trump wins immunity & annual report season hushes ASX

There are more pages in this discussion • 271 more messages in this thread...

First 201 Last

Add RAP (ASX) to my watchlist

You have all the information available to you, good and bad, and...

Top Stories

Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng

Red Hill Minerals Signs $6.5 Million Agreement with Peel Mining to Explore Curnamona Project, NSW

Fast-track assaying yields 182 g/t gold for iTech at new NT play

Saturn’s stars have aligned for the gold explorer’s Apollo Project

Climate change to drive market trends to the moon

The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

KGL sniffs 19% Cu from drilling at Rockface play in NT

Tivan and EARTH AI gear up to commence fresh drilling at Sandover lead-silver project, NT

Week 27 Wrap: "Election year" is here as UK Labour win contrasts France; Trump wins immunity & annual report season hushes ASX

Featured News